AbCellera Biologics Inc (ABCL) NPV

Sell:$4.52Buy:$4.53$0.02 (0.45%)

NASDAQ:0.12%
Market closed | Prices delayed by at least 15 minutes
Sell:$4.52
Buy:$4.53
Change:$0.02 (0.45%)
Market closed | Prices delayed by at least 15 minutes
Sell:$4.52
Buy:$4.53
Change:$0.02 (0.45%)
Market closed | Prices delayed by at least 15 minutes

Director deals

Listed below are trades carried out by directors and other individuals which are required to be notified to the market.

Recent deals

DateName and position (if held)Deal typeNumber of
shares dealt
Price per
share
Value of
trade
Shares
remaining
8 November 2023
John Salvatore MontalbanoDirector
Buy
Regular purchase transaction
10,000$4.46$44,600.0086,000
6 November 2023
John Salvatore MontalbanoDirector
Buy
Regular purchase transaction
20,000$4.64$92,800.0076,000
22 September 2023
Michael Reuben HaydenDirector
Buy
Regular purchase transaction
20,000$4.91$98,200.001,323,397
12 September 2023
Veronique LecaultCOO
Buy
Regular purchase transaction
20,000$5.19$103,800.002,040,122
8 August 2023
Michael Reuben HaydenDirector
Buy
Regular purchase transaction
30,000$5.90$177,000.001,303,397
26 May 2023
Carl L G HansenChairman/CEO
Buy
Regular purchase transaction
153,000$6.52$997,728.3056,012,493
26 May 2023
Andrew BoothCFO
Buy
Regular purchase transaction
14,500$6.85$99,325.00153,000

End of results. Director deals are only available for the last 12 months.

5 most significant deals

DateName and position (if held)Deal typeNumber of
shares dealt
Price per
share
Value of
trade
Shares
remaining
26 May 2023
Carl L G HansenChairman/CEO
Buy
Regular purchase transaction
153,000$6.52$997,728.3056,012,493
8 August 2023
Michael Reuben HaydenDirector
Buy
Regular purchase transaction
30,000$5.90$177,000.001,303,397
12 September 2023
Veronique LecaultCOO
Buy
Regular purchase transaction
20,000$5.19$103,800.002,040,122
26 May 2023
Andrew BoothCFO
Buy
Regular purchase transaction
14,500$6.85$99,325.00153,000
22 September 2023
Michael Reuben HaydenDirector
Buy
Regular purchase transaction
20,000$4.91$98,200.001,323,397

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Director deal information provided by Factset.